Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Otsuka Holdings Company ADR (OTSKY)

Otsuka Holdings Company ADR (OTSKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Otsuka Holdings Company ADR

Description:

Otsuka Holdings Co Ltd was established on July 8, 2008 as a holding company. The Company is a healthcare company that aims to contribute to the well-being of people in various regions through its products. It operates in two core businesses: the pharmaceutical business, which supports the diagnosis and treatment of disease; and the nutraceutical business, which supports the maintenance and improvement of day-to-day well-being. The Company conducts its business in four reportable segments: pharmaceuticals, nutraceuticals, consumer products and other businesses. Its pharmaceuticals segment is composed of research and development, production and sales of prescription drugs and clinical nutrition. Its nutraceuticals segment is composed of production and sales of functional foods, over-the-counter drugs and supplements. Its consumer products segment is composed of mineral water, beverages, and food products. Its other segment encompasses other operations, composed of logistics, warehousing, chemical products, and electronics. The Company is subject to applicable laws and regulations in Japan and other jurisdictions that regulate pharmaceutical products, including approval processes that involve significant uncertainties in terms of the length of time required for approval and whether the products meet the criteria of regulatory authorities with respect to efficacy and safety requirements.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 0.61

Growth:

1-Year Return 59.74%
3-Year Return 66.52%
5-Year Return 35.36%

Per-Share Information:

Next Earnings Date N/A
Next Ex-Dividends Date 09/25/14
Dividend Payable Date 12/16/14
Dividend Payout Ratio 0.00%

OTSKY Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 11.05
Price/Book 1.23
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar